Executive Leadership Team
President
Read BiographyGerald Joyce serves as the president of the Salk Institute. In addition, he is a professor in the Jack H. Skirball Center for Chemical Biology and Proteomics.
Joyce began his scientific career at Salk as a PhD student and then a postdoctoral scholar. He returned as a faculty member in 2017 and served as senior vice president and chief science officer from 2022 to 2023. His research program focuses on the development of novel RNA and DNA enzymes and their potential application in clinical diagnostics and therapeutics. His research has led to the development of the first self-replicating RNA enzyme that is capable of exponential growth and evolution.
From 2014 to 2021, Joyce served as the director of the Genomics Institute of the Novartis Research Foundation (GNF). He has served previously as dean of the faculty at Scripps Research and as a member of the Technology Advisory Council of BP.
Joyce graduated with a BA from the University of Chicago in 1978 and both an MD and PhD from the University of California San Diego in 1984. He completed his postgraduate medical training at Mercy Hospital in San Diego and postdoctoral research training at the Salk Institute.
Vice President, People & Culture
Read BiographySue Bacino is Vice President of People & Culture. She leads the Office of Human Resources (HR), Pre & Postdoctoral Office (PDO), and Office of Diversity, Equity & Inclusion (DEI). She oversees the advancement of Salk’s mission through the recruiting, retention, and support of a diverse, world-class faculty and staff.
Prior to Salk, Bacino served as head of HR for a medical device company in Carlsbad, California. In that role—reporting to the CEO and serving as a key member of the leadership team—Bacino was responsible for the implementation of all HR-related processes and functions. Before that role, she held the same position at Genomics Institute of the Novartis Research Foundation, where she partnered with scientific leadership on recruiting, engaging and retaining talent for this Novartis research site located in San Diego.
She has also served as executive director of HR for Amylin Pharmaceuticals, and she held various leadership positions at Vical Incorporated before Amylin. Her experience beyond the med-tech field includes serving as vice president of HR for Father Joe’s Villages and Breg, Inc.
Bacino earned her bachelor of arts at UC Davis.
Chief Financial Officer
Read BiographyKimberly Castillo has served as the Chief Financial Officer of the Salk Institute for Biological Studies since April 2017, having joined the Institute in 2007. In her role, she plays a vital part in advancing Salk's mission by managing its fiscal operations, which encompass financial reporting, accounting, treasury functions, annual budgeting and projections, payroll, tax reporting and compliance, financial information systems, post-award administration, and procurement.
Before her tenure at Salk, Castillo operated her own consulting practice, providing financial and accounting services as well as outsourced CFO support to non-profit organizations in California and Washington, particularly in the biomedical research sector. She also held the position of Senior Managing Director of Financial Operations at Rady Children’s Hospital and Health Center. Prior to that, Castillo spent 12 years at Deloitte & Touche LLP, where she was a designated not-for-profit specialist and served as a national resource for non-profit accounting and audits of federal financial assistance and biomedical research organizations.
Castillo is a Certified Public Accountant and earned her BS in Accounting from San Diego State University.
Vice President, Chief Science Officer
Professor
Jan Karlseder is Salk’s vice president and chief science officer (CSO). He is also a professor in the Molecular and Cell Biology Laboratory, director of the Paul F. Glenn Center for Biology of Aging Research, and the Donald and Darlene Shiley Chair for Research on Aging.
His lab is focused on telomeres—the caps at the ends of chromosomes that shorten as we get older. Telomeres regulate genome stability, inflammation, cancer initiation, and other crucial cell activities. Karlseder believes that a better understanding of telomere integrity and length regulation will lead to a deeper understanding of the aging process and age-related disease, as well as help uncover new ways to inhibit cancer.
Karlseder has received numerous awards and honors, including the V Foundation Award for Developing Scientists, a Forbeck Scholar Award, and the Glenn Award for Research in Biological Mechanisms of Aging. He earned his BS in Biology at the University of Innsbruck and PhD in Molecular Biology at the University of Vienna in Austria. He completed his postdoctoral fellowship at Rockefeller University in New York.
General Counsel
Read BiographyJulia Miller is the General Counsel of the Salk Institute for Biological Studies. She joined the Institute in January, 2010 and advises on a wide range of legal matters associated with the administration and management of the institute and in support of the scientific research mission, including contracts, intellectual property protection and technology transfer, legal proceedings, corporate governance, nonprofit, insurance, risk management and employment matters.
Miller serves as Corporate Secretary and is the management liaison for the Governance Committee of the Board, working with the Chair to manage the Committee’s responsibilities under its charter.
Prior to joining the institute, Miller was an attorney in the San Diego office of Paul, Hastings, Janofsky & Walker LLP, practicing in the corporate department and, earlier in her career, in litigation. While at Paul Hastings, she focused on a wide range of business transactions and intellectual property matters for life science and technology clients. Miller has experience in intellectual property due diligence in merger and acquisition transactions and strategic counseling on various patent, trade secret and corporate matters. She also has represented clients in patent infringement litigation, patent license disputes and trade secret theft claims.
Miller holds a bachelor's degree in Cell Biology & Biochemistry from U.C. San Diego and a Juris Doctor, magna cum laude, from Boston University.
Vice President, Chief Operating Officer
Read BiographySuzanne Page joined the Salk Institute as Vice President and Chief Operating Officer (COO) in 2024. She oversees operational functions, including facilities, security services, environmental health and safety, information technology, and campus events. As a key member of the Executive Leadership Team, she works closely with Salk’s President, Chief Science Officer, and other leaders to define and achieve Institute goals.
Prior to Salk, Page held the role of VP of Operations at Steadman Philippon Research Institute in Vail, Colorado, where she led operations and sponsored research, and collaborated with researchers to lead laboratories for the nonprofit research institute. She previously served as COO at Longeveron, Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company in Miami, Florida, where she helped launch the start-up as its first employee, built out manufacturing and R&D facilities, and managed all operations, grants, clinical trials, and business matters. Prior to that, she held the position of Executive Director of Research Administration and Revenue Cycle at the University of Miami, where she helped transform the university’s research programs by creating a new department designed to accelerate research, increase revenue, and foster compliance.
Page earned her Bachelor of Science in Finance and Juris Doctor at Indiana University. She holds bar memberships in California, Illinois, and Washington.
